Document is current
Any future updates will be listed below
-
Authors
Liu, Yu
Liu, Wenbing https://orcid.org/0000-0003-4562-5541
Lai, Anli
Mei, Yihan
Wang, Ying
Wei, Hui https://orcid.org/0000-0003-1674-3792
Rao, Qing https://orcid.org/0000-0001-6721-1337
Gu, Runxia
Mi, Yingchang
Wang, Min https://orcid.org/0000-0003-1637-0324
Wang, Jianxiang https://orcid.org/0000-0001-9437-9151
Qiu, Shaowei https://orcid.org/0000-0003-3866-0066
- License Information
-
More Information
Article History
Received: 3 July 2024
Revised: 30 August 2024
Accepted: 5 September 2024
First Online: 16 September 2024
Competing interests
: JW: Advisor for AbbVie. The remaining authors declare no competing interests.
: The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Institutional Review Board of the Institute of Hematology and Blood Diseases Hospital (Ref: NKRDP2021005-EC-2). Informed consent was obtained from all patients.
